The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 08, 2015

Filed:

Jul. 21, 2009
Applicants:

Russ P. Carstens, Wynnewood, PA (US);

Claude Warzecha, Philadelphia, PA (US);

John Hogenesch, Wallingford, PA (US);

Trey Sato, Madison, WI (US);

Inventors:

Russ P. Carstens, Wynnewood, PA (US);

Claude Warzecha, Philadelphia, PA (US);

John Hogenesch, Wallingford, PA (US);

Trey Sato, Madison, WI (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); C12P 21/06 (2006.01); C07K 14/47 (2006.01); G01N 33/574 (2006.01); C12N 15/113 (2010.01); A61K 49/00 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4702 (2013.01); C12N 15/113 (2013.01); C12Q 1/68 (2013.01); C12Q 1/6886 (2013.01); G01N 33/574 (2013.01); C12N 2310/14 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); G01N 33/68 (2013.01);
Abstract

Methods and compositions for diagnosis and prognosis of mammalian carcinoma or cancer derived from primary epithelial cells and tissue fibrosis are designed using newly identified epithelial cell-type specific splicing factors ESRP1 and ESRP2, which have roles in tumor suppression. Diagnostic reagents for the detection of these splicing factors in nucleotide or protein form are useful in such methods. Therapeutic compositions can provide epithelial cells with these factors to maintain FGFR2 and assist in suppressing metastasis. A high throughput splicing assay to identify compounds that change splicing events is described. RNCP1 is also identified as a splicing factor and a diagnostic for conditions characterized by inappropriate FGFR2-splicing.


Find Patent Forward Citations

Loading…